# GoodRx Holdings, Inc. (GDRX) FY2026 YTD Q2 P&L / Income Statement

- Company: GoodRx Holdings, Inc. (GDRX)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001809519-26-000152
- Page: https://plicit.ai/financials/gdrx/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/gdrx-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 394,417,000 US dollars
- **Cost of revenue (calculated)**: 41,155,000 US dollars
- **Gross profit (calculated)**: 353,262,000 US dollars
- **Operating expenses (calculated)**: 315,621,000 US dollars
- **Operating income**: 37,641,000 US dollars
- **Total other expense, net**: negative 16,536,000 US dollars
- **Income before income taxes**: 21,105,000 US dollars
- **Income tax expense**: 11,400,000 US dollars
- **Net income**: 9,705,000 US dollars
- **Prescription transactions revenue**: 220,082,000 US dollars
- **Subscription revenue**: 52,907,000 US dollars
- **Pharma Direct revenue**: 113,858,000 US dollars
- **Other revenue**: 7,570,000 US dollars
- **Cost of revenue, exclusive of depreciation and amortization presented separately below**: 41,155,000 US dollars
- **Product development and technology**: 56,888,000 US dollars
- **Sales and marketing**: 163,039,000 US dollars
- **General and administrative**: 51,633,000 US dollars
- **Depreciation and amortization**: 44,061,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.